Chad vs Mexico: Access to anti-retroviral drugs, male
Chad
67.0%
in 2024
Mexico
67.0%
in 2024
Chad rank
78th
Mexico rank
78th
Access to anti-retroviral drugs, male over time
- Chad
- Mexico
How they compare
Chad currently reports 67.0% against 67.0% in Mexico, a difference of 0.0%.
Across all 25 years both countries report, Mexico has been ahead every year.
Chad ranks 78th and Mexico ranks 78th of 141 countries.
Mexico has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Chad | Mexico | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 3.1% | 20.0% | 16.9% | Mexico |
| 2010s | 25.3% | 40.3% | 15.0% | Mexico |
| 2020s | 55.0% | 63.2% | 8.2% | Mexico |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Chad or Mexico?
- Chad, at 67.0% against 67.0% in Mexico as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Chad and Mexico?
- 0.0%, with Chad ahead.
- How many years of comparable data are there for Chad and Mexico?
- 25 years are reported by both, from 2000 to 2024.
- How do Chad and Mexico rank globally for access to anti-retroviral drugs, male?
- Chad ranks 78th and Mexico ranks 78th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.